https://www.selleckchem.com/pr....oducts/Glycyrrhizic-
Copyright© Bentham Science Publishers; For any queries, please email at [email protected] use of peptides as drug carriers across the blood-brain barrier (BB has increased significantly during the last decades. PepH3, a seven residue sequence (AGILKRW) derived from the α-helical domain of the dengue virus type-2 capsid protein, translocates across the BBB with very low toxicity. Somehow predictably from its size and sequence, PepH3 is degraded in serum relatively fast. Among strategies to increase peptide half-life